mRNA vaccine-induced antibody profiles against SARS-CoV-2 variants

Though early data indicate that the SARS-CoV-2 mRNA vaccines produced by Moderna and Pfizer-BioNTech are extremely effective, little is known about the durability of the elicited immune response and how well these vaccines protect against emergent SARS-CoV-2 variants. In their study published recently in Nature, Wang et al. present crucial data showing that the documented mutations indeed diminish the neutralization potency of the mRNA vaccines, though…

Read more »»